Legend Biotech Corporatio... (LEGN)
NASDAQ: LEGN
· Real-Time Price · USD
37.47
-0.24 (-0.64%)
At close: Aug 15, 2025, 3:59 PM
37.50
0.09%
After-hours: Aug 15, 2025, 06:06 PM EDT
Legend Biotech Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 797.73M | 728.3M | 627.24M | 520.18M | 455.99M | 342.8M | 285.14M | 233.31M | 164.66M | 103.3M | 107.79M | 119.15M | 108.67M | 116.94M | 89.79M | 91.58M | 86.44M | 77.81M |
Cost of Revenue | 304.95M | 251.19M | 240.3M | 204.18M | 192.19M | 174.41M | 149.56M | 134.73M | 116.71M | 100.98M | 146.71M | 123.75M | 98.28M | 81.35M | 71.07M | 71.07M | 71.07M | 71.07M |
Gross Profit | 492.79M | 477.12M | 386.94M | 316M | 263.8M | 168.38M | 135.58M | 98.58M | 47.95M | 2.33M | -38.92M | -4.59M | 10.39M | 35.59M | 18.72M | 20.51M | 15.37M | 6.74M |
Operating Income | -217.05M | -236.64M | -303.86M | -350.52M | -347.46M | -394.57M | -383.56M | 56.74M | -19.02M | -49.65M | -17.78M | -428.48M | -413.76M | -383.73M | -388.29M | -353.28M | -292.47M | -259.25M |
Interest Income | 52.81M | 59.39M | 61.2M | 64.85M | 66.64M | 54.78M | 47.66M | 35.25M | 16.87M | 11.68M | 5.38M | 917.5K | 1.2M | 1.2M | 844K | 421K | 100K | 100K |
Pretax Income | -304.74M | -197.47M | -158.13M | -345.46M | -287.06M | -467.93M | -520.12M | -509.03M | -531.34M | -525.57M | -454.69M | -407.3M | -447.88M | -346.4M | -386.21M | -355.63M | -297.29M | -340.58M |
Net Income | -325.77M | -218.15M | -177.03M | -348.13M | -285.01M | -465.95M | -518.25M | -509.31M | -532.06M | -526.16M | -456.14M | -408.6M | -449.04M | -347.39M | -386.21M | -355.7M | -296.86M | -340.15M |
Selling & General & Admin | 310.18M | 300.54M | 284.26M | 263.52M | 233.15M | 216.92M | 200.93M | 191.05M | 183.94M | 180.25M | 174.05M | 191.5M | 180.74M | 161.28M | 149.48M | 112.88M | 96.87M | 84.9M |
Research & Development | 400.53M | 414.5M | 413.54M | 414.8M | 415.13M | 398.29M | 382.22M | 357.29M | 365.95M | 338.99M | 335.45M | 341.19M | 308.99M | 323.62M | 313.35M | 293.78M | 285.12M | 255.23M |
Other Expenses | -869K | -869K | -1.31M | -28.93M | -28.62M | -28.62M | -28.18M | 169K | -2.23M | -2.23M | -2.74M | -4.38M | -1.97M | -4.2M | -5.01M | -3.54M | -3.27M | -1.04M |
Operating Expenses | 709.84M | 714.18M | 691.22M | 666.94M | 637.03M | 602.61M | 576.27M | 545.44M | 546.11M | 516.8M | 506.56M | 531.12M | 489.07M | 482.92M | 461.35M | 405.18M | 380.66M | 340.13M |
Interest Expense | 20.96M | 21.2M | 21.61M | 22.28M | 22.45M | 22.16M | 21.79M | 20.84M | 18.41M | 14.87M | 10.75M | 6.49M | 3.45M | 1.86M | 900K | 338K | 220K | 256K |
Selling & Marketing Expenses | 134.16M | 164.23M | 147.48M | 132.23M | 109.06M | 100.43M | 94.16M | 86.3M | 84.06M | 90.07M | 93.42M | 120.41M | 121.08M | 110.43M | 102.54M | 73.91M | 63.67M | 56.44M |
Cost & Expenses | 1.01B | 965.37M | 931.52M | 871.12M | 829.23M | 777.02M | 725.83M | 680.17M | 662.82M | 617.78M | 571.92M | 573.52M | 506.01M | 482.92M | 461.35M | 405.18M | 380.66M | 340.13M |
Income Tax Expense | 21.03M | 20.67M | 18.89M | 2.67M | -2.05M | -1.99M | -1.86M | 283K | 723K | 590K | 1.46M | -2.41M | -6.06M | -6.21M | -5.9M | -2.11M | 877K | 876K |
Shares Outstanding (Basic) | 92.07M | 91.88M | 91.43M | 91.36M | 91.3M | 91M | 90.96M | 90.89M | 87.63M | 82.62M | 79.52M | 78.48M | 77.44M | 77.17M | 73.3M | 72.48M | 69.25M | 66.57M |
Shares Outstanding (Diluted) | 92.07M | 91.88M | 91.43M | 91.36M | 91.3M | 91M | 90.96M | 90.89M | 87.63M | 82.62M | 79.52M | 78.48M | 77.44M | 77.17M | 73.3M | 72.48M | 69.25M | 66.57M |
EPS (Basic) | -3.54 | -2.38 | -1.94 | -3.82 | -3.14 | -5.22 | -5.92 | -6.02 | -6.42 | -6.64 | -5.82 | -5.32 | -5.98 | -4.8 | -5.48 | -5.16 | -4.42 | -5.6 |
EPS (Diluted) | -3.54 | -2.38 | -1.94 | -3.82 | -3.14 | -5.22 | -5.92 | -6.02 | -6.42 | -6.64 | -5.82 | -5.32 | -5.98 | -4.8 | -5.48 | -5.16 | -4.42 | -5.6 |
EBITDA | -260.44M | -153.44M | -113.16M | -301.26M | -243M | -429.53M | -487.8M | -477.77M | -507.68M | -505.46M | -429.68M | -391.8M | -431.93M | -328.68M | -378.46M | -348.44M | -293.72M | -340.33M |
EBIT | -283.78M | -176.27M | -136.52M | -323.17M | -264.61M | -445.78M | -498.32M | -488.19M | -512.93M | -510.71M | -434.93M | -391.8M | -435.43M | -335.53M | -399.01M | -373.01M | -314.79M | -358.05M |
Depreciation & Amortization | 23.34M | 22.84M | 23.36M | 21.91M | 21.61M | 16.24M | 15.7M | 15.6M | 15.54M | 19.65M | 18.39M | 16.85M | 15.24M | 14.49M | 14.24M | 11.89M | 10.86M | 10.31M |